RxDoctor Payments Data

Omar Yacob

Interventional Cardiology · Conway, ARNPI 1417442369

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,379 of the $5,361 with a category attached, or 63.0%. 18 manufacturers reported payments, led by Boston Scientific at 30.6% of the total. 2025 is the largest year on record at $2,324, more than ten times the $51 reported in 2021. That places this record below the midpoint for interventional cardiology clinicians in AR, where the typical reported total is $7,561.

$5,361in general payments, 2019–2025

Across 94 payments — averaging $57.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Abbott$1K
  • Shockwave Medical, Inc$447
  • Medtronic$393
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$347
  • AstraZeneca$313
  • plus $813 from 12 others

What the payments were for

  • Travel & lodging$1,67431%
  • Food & beverage$3,37963%
  • Education$3086%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,361 in reported general payments places this provider in the 35th percentile of 89 interventional cardiology providers in Arkansas.

See all interventional cardiology providers in Arkansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$15,252
Metoprolol Succinate41$455
Torsemide21$312
Atorvastatin Calcium26$178
ClopidogrelClopidogrel Bisulfate29$161
Lisinopril20$155
Losartan Potassium23$126
Ezetimibe15$124
Carvedilol12$105
Spironolactone18$56
Furosemide14$28

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$34$15,25218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 89 interventional cardiology providers in Arkansas.

Other interventional cardiology in Conway

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →